Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, is disclosed.

Ref: AHCL/2026-27/C047 October 20, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 Scrip Code – 544350 Symbol : AGARWALEYE Dear Sir / Madam, Sub: Outcome of the Board Meeting held on October 20, 2026 Ref: - Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited and their respective shareholders and creditors (“Scheme”) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 - Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) In continuation to our earlier letter dated October 05, 2026, intimating the receipt of Sanction from the Hon’ble National Company Law Tribunal, Chennai Bench (“NCLT”), towards the above referred Scheme and pursuant to the captioned subject & reference, we wish to inform that the Board of Directors of Dr. Agarwal’s Health Care Limited (“Company” / “Transferee Company”) at its meeting held today, i.e., Tuesday, October 20, 2026, has, inter-alia, noted, considered & approved the following: A. Effectiveness of the Scheme of Amalgamation The certified copy of the Order dated September 30, 2026, passed by the NCLT, sanctioning the Scheme was taken on record. The Board further noted that with the filing of the certified copy of the NCLT Order in Form INC-28 with the Registrar of Companies (“ROC”), Chennai on October 15, 2026, all conditionalities specified under Clause 24 of the Scheme stand satisfied. Accordingly, the Scheme shall become effective and operative from November 01, 2026 (Effective Date), with the Appointed Date being April 01, 2026. B. Alteration of the Authorized Share Capital of the Company Pursuant to Clause 21 and 22 of the Scheme and Section 232(3)(i) of the Companies Act, 2013: • The existing authorized share capital of Dr. Agarwal’s Eye Hospital Limited (“Transferor Company”) comprising 2,00,00,000 Equity Shares of face value of ₹10 each stand reclassified into 20,00,00,000 Equity Shares of face value of ₹1 each; and • Upon the Scheme becoming effective on November 01, 2026, the aforesaid entire re- classified authorized share capital of the Transferor Company (₹ 20,00,00,000/-) shall stand automatically combined and merged with the existing authorized share capital of the Transferee Company without any further act or deed as tabled below: Authorised Share Capital of Dr. Agarwal’s Health Care Limited (Transferee Company) (Prior to effectiveness of the Scheme) PARTICULARS INR a) 54,20,00,000 Equity shares of INR 1 each 54,20,00,000 /- b) 35,80,000 fully and compulsorily convertible non-cumulative 35,80,00,000/- participating preference shares of INR 100 each TOTAL 90,00,00,000/- Authorised Share Capital of Dr. Agarwal’s Health Care Limited (Transferee Company) (Post effectiveness of the Scheme) PARTICULARS INR a) 74,20,00,000 Equity shares of INR 1 each 74,20,00,000 /- b) 35,80,000 fully and compulsorily convertible non-cumulative 35,80,00,000/- participating preference shares of INR 100 each TOTAL 110,00,00,000/- C. Fixation of Record Date for Allotment of Consideration Shares to the eligible shareholders of the Transferor Company pursuant to the Scheme of Amalgamation In compliance with Regulation 42 of the SEBI Listing Regulations and pursuant to the Scheme, the Board of Directors of the Transferee Company, in consultation with the Board of Directors of the Transferor Company, has fixed Wednesday, November 18, 2026 as the Record Date for determining the eligible equity shareholders of the Transferor Company entitled to receive Consideration Shares as per the approved Share Exchange Ratio below: “23 (Twenty-Three) fully paid-up Equity Shares of face value of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 (Two) fully paid-up Equity Shares of face value of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited” The meeting commenced at 05:30 P.M. IST and concluded at 06:00 P.M. IST today. We request you to kindly take the above information on record. For Dr. Agarwal’s Health Care Limited Thanikainathan Arumugam Company Secretary and Compliance Officer